Leveraging structure determination with fragment screening for infectious disease drug targets: MECP synthase from Burkholderia pseudomallei

Leveraging structure determination with fragment screening for infectious disease drug targets: MECP synthase from Burkholderia pseudomallei

As part of the Seattle Structural Genomics Center for Infectious Disease, we seek to enhance structural genomics with ligand-bound structure data which can serve as a blueprint for structure-based drug design. We have adapted fragment-based screening methods to our structural genomics pipeline to ge...

Full description

Bibliographic Details
Main Authors: Begley, Darren W., Hartley, Robert C., Davies, Douglas R., Edwards, Thomas E., Leonard, Jess T., Abendroth, Jan, Burris, Courtney A., Bhandari, Janhavi, Myler, Peter J., Staker, Bart L., Stewart, Lance J.
Format: Online
Language:English
Published: Springer Netherlands 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123455/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123455/

Similar Items